Victoria Miller
Nurse Practitioner · Port Neches, TXNPI 1437535507
Payments from drug & device makers
Across 307 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$786
- Novo Nordisk$657
- AstraZeneca$475
- Pfizer$400
- Lilly USA, LLC$323
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,410100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 89 | $1,220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $786 |
| Novo Nordisk | 37 | $657 |
| AstraZeneca | 27 | $475 |
| Pfizer | 21 | $400 |
| Lilly USA, LLC | 17 | $323 |
| GSK | 9 | $177 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $169 |
| Idorsia Pharmaceuticals US Inc | 9 | $160 |
| Corcept Therapeutics | 3 | $120 |
| Amgen | 7 | $112 |
| Sanofi-aventis U.S. LLC | 4 | $79 |
| Dexcom, Inc. | 3 | $67 |
| Abbott | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Bayer | 3 | $59 |
| Esperion Therapeutics, Inc. | 3 | $54 |
| Antares Pharma, Inc. | 2 | $53 |
| Exact Sciences | 3 | $53 |
| Amarin Pharma, Inc. | 3 | $46 |
| Optinose US, Inc. | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $32 |
| Novartis | 2 | $30 |
| Merck | 2 | $27 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$5,412 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 67 | $81,662 |
| EliquisApixaban | 67 | $67,529 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $62,141 |
| FarxigaDapagliflozin Propanediol | 34 | $28,627 |
| JardianceEmpagliflozin | 16 | $24,539 |
| MyrbetriqMirabegron | 12 | $15,748 |
| TrulicityDulaglutide | 11 | $12,773 |
| MounjaroTirzepatide | 13 | $11,936 |
| JanuviaSitagliptin Phosphate | 13 | $10,796 |
| Repatha SureclickEvolocumab | 12 | $6,206 |
| Rosuvastatin Calcium | 236 | $4,105 |
| VascepaIcosapent Ethyl | 12 | $4,034 |
| Gabapentin | 164 | $2,556 |
| Ezetimibe | 93 | $2,209 |
| Atorvastatin Calcium | 148 | $1,588 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $657 | $81,66267 claims |
| PfizerEliquis | $400 | $67,52967 claims |
| GSKTrelegy Ellipta | $177 | $62,14160 claims |
| AstraZenecaFarxiga | $475 | $28,62734 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $323 | $24,71024 claims |
| MerckJanuvia | $27 | $10,79613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Port Neches
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.